登录 注册 会员服务 联系我们

Bendamustine: a review of pharmacology, clinical use and immunological effects (Review)

  • Published:2022-05-03 Issue:6 Volume:47 Page:
  • ISSN:1021-335X
  • Container-title:Oncology Reports
  • language:
  • Short-container-title:Oncol Rep

Author:

Lalic Hrvoje1,Aurer Igor2,Batinic Drago3,Visnjic Dora1,Smoljo Tomislav1,Babic Antonija4

Affiliation:

1. Laboratory of Cell Biology and Croatian Institute for Brain Research, University of Zagreb School of Medicine, 10 000 Zagreb, Croatia

2. Division of Hematology, Department of Internal Medicine, University Hospital Center Zagreb, 10 000 Zagreb, Croatia

3. Department of Physiology, University of Zagreb School of Medicine, 10 000 Zagreb, Croatia

4. Department of Laboratory Immunology, Clinical Department of Laboratory Diagnostics, University Hospital Center Zagreb, 10 000 Zagreb, Croatia

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference104 articles.

1. Bendamustine: Rebirth of an Old Drug;Cheson;J Clin Oncol,2009

2. Bendamustine: Mechanism of action and clinical data;Cheson;Clin Adv Hematol Oncol,2011

3. Bendamustine in B-cell malignancies: The new 46-year-old kid on the block;Gandhi;Clin Cancer Res,2009
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3